{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-038936","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.283353+00:00","generated_at":"2026-06-08T03:28:02.659965+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"X4 Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00","bullets":["Received Nasdaq letter on Nov 13, 2023 for non-compliance with minimum $1.00 bid price rule.","Common stock closing bid price below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until May 13, 2024, to regain compliance.","If not compliant by deadline, may request additional 180 days if other listing standards are met.","Considering potential reverse stock split to cure deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-038936","json":"https://secwatch.observer/filing/0001628280-23-038936.json","markdown":"https://secwatch.observer/filing/0001628280-23-038936.md","text":"https://secwatch.observer/filing/0001628280-23-038936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/0001628280-23-038936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/xfor-20231113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:28:02.659965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}